Career history of Rajeev Chillakuru
Former positions of Rajeev Chillakuru
Companies | Position | Start | End |
---|---|---|---|
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 11/05/2009 | 30/01/2012 |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Corporate Officer/Principal | 31/12/2003 | 31/12/2003 |
HALOZYME THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
MOMENTA PHARMACEUTICALS, INC. | Corporate Officer/Principal | - | - |
Training of Rajeev Chillakuru
State University of New York at Buffalo | Undergraduate Degree |
Statistics
International
United States | 6 |
Operational
Corporate Officer/Principal | 4 |
Undergraduate Degree | 1 |
Sectoral
Health Technology | 4 |
Distribution Services | 2 |
Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
HALOZYME THERAPEUTICS, INC. | Health Technology |
Private companies | 3 |
---|---|
Virdante Pharmaceuticals, Inc.
Virdante Pharmaceuticals, Inc. Medical DistributorsDistribution Services Virdante Pharmaceuticals, Inc. develops and commercializes drugs for auto-immune and inflammatory disorders. The company's products incorporate a proprietary 'sialic switch' technology to improve the anti-inflammatory properties of antibodies. It was founded in 2008 and is headquartered in Cambridge, MA. | Distribution Services |
Momenta Pharmaceuticals, Inc.
Momenta Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Momenta Pharmaceuticals, Inc. operates as a biotechnology company that focuses on the discovery and development of novel biologic therapies for the treatment of rare immune-mediated diseases. Its products include the Glatiramer acetate injection and Enoxaparin Sodium injection. The company was founded by Ram Sasisekharan, Paul R. Schimmel, and Ganesh Venkatraman Kaundinya in May 2001 and is headquartered in Cambridge, MA. | Health Technology |
CuraGen Corp.
CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Health Technology |
- Stock Market
- Insiders
- Rajeev Chillakuru
- Experience